Stay updated with breaking news from Pharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Conference Call and Live Audio Webcast Scheduled for Today, April 3, 2023, at 10:00 a.m. ET Corporate Highlights Jody Staggs named President and Chief...
SWK (NASDAQ:SWKH – Get Rating) is set to announce its earnings results on Monday, March 27th. SWK Price Performance Shares of NASDAQ:SWKH opened at $17.88 on Friday. SWK has a 1 year low of $16.06 and a 1 year high of $19.99. The stock has a market capitalization of $229.22 million, a price-to-earnings ratio of […]
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2,... | March 23, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2, HERKULES-3, FLAGSHP-1, and THUNDERBBOLT-1 trials ...
/PRNewswire/ -- The "Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) Workshop" training has been added to...